This educational poster is divided into two parts, in which we analyzed the common features and the particular characteristics of Budd-Chiari syndrome.
I. Current Imaging Aspects
The imaging appearance of Budd-Chiari syndrome varies based on the disease stage, from acute to chronic.
1. Acute Form (less than a month since disease onset)
In acute BCS, imaging findings correspond to histologic changes of liver congestion and edema [2].
CT Findings:
- Diffuse enlargement with low attenuation due to congestion;
- Peripheral areas show reduced enhancement (due to portal and sinusoidal stasis), while the central parenchyma exhibits greater contrast uptake;
- Thrombotic material may be present within the hepatic veins, indicating vascular obstruction.
MRI Findings:
- Decreased signal on T1-weighted images;
- Heterogeneously increased signal on T2-weighted images, especially in the peripheral region;
- T1 + Gd: The differential increase in contrast between the central and peripheral liver regions results in greater contrast enhancement of the parenchyma adjacent to the inferior vena cava [4, 5].
The enhanced uptake pattern of the central and peripheral liver regions creates a mottled 'nutmeg liver' appearance. Key imaging signs of hepatic venous outflow obstruction include absent or reversed hepatic vein flow, without venous collaterals, features that help differentiate acute from subacute cases. Common associated findings include ascites and congestive splenomegaly, indicating liver dysfunction [1].


2. Subacute Form (between one and six months since disease onset)
Imaging Findings: Volume redistribution and collateral vessel formation, these imaging characteristics help differentiate subacute BCS from its acute form [2, 6].
In subacute BCS, intrahepatic and extrahepatic collaterals improve drainage, creating more homogeneous enhancement than in acute BCS. However, persistent congestion and edema indicate ongoing vascular compromise.
Subacute and chronic BCS have overlapping imaging features, but chronic BCS shows less edema, more fibrosis, regenerative nodules, and well-developed collaterals. Clinical history, labs, and imaging follow-up are key for differentiation [4].


3. Chronic Form (more than six months since disease onset)
Imaging Findings: well-developed intrahepatic and subcapsular collaterals, caudate lobe hypertrophy, peripheral atrophy, irregular liver contour, regenerative nodules, and significant liver size reduction. Edema is minimal, with advanced stages showing progressive atrophy due to fibrosis and tissue remodeling.
Chronic BCS shows portal hypertension with portal vein dilation (>13 mm), hepatofugal flow, enlarged mesenteric and splenic veins, paraumbilical vein recanalization, portosystemic collaterals, splenomegaly, and ascites [7].
Chronic BCS may lead to cirrhosis complications like variceal bleeding, hepatic encephalopathy, and hepatocellular carcinoma.


II. Budd-Chiari Syndrome: Particular Imaging Aspects
1. HNF-like regenerative nodules
BCS is characterized by regenerative nodules, typically multiple and variable in size, due to hepatic blood supply imbalance [8]. Insufficient perfusion causes hepatocyte atrophy, while compensatory hyperplasia occurs in areas with preserved arterial inflow. These nodules are primarily supplied by arterial blood, leading to prominent arterial-phase hyperenhancement on imaging [4].
Hepatic regenerative nodules require differentiation from other hypervascular lesions, including hemangiomas, hepatic adenomas, dysplastic nodules, HCC, and metastases. Due to overlapping imaging features, accurate identification is essential to prevent misdiagnosis and mismanagement. Magnetic resonance imaging, particularly the hepatobiliary phase, is critical for diagnosis in BCS, as it highlights similarities with focal nodular hyperplasia (FNH).



2. BCS with predominantly lobar involvement of the hepatic parenchyma
The number of hepatic veins that must be occluded to cause clinically significant hemodynamic alterations remains a subject of ongoing debate. A key question is whether the obstruction of a single hepatic vein is sufficient to disrupt hepatic circulation and cause symptomatic disease, or if compensatory mechanisms, such as drainage through the remaining patent hepatic veins, mitigate significant hemodynamic consequences [9].
BCS diagnosis relies on clinical, biological, and imaging findings. Symptoms usually occur when at least two of the three hepatic veins are occluded, leading to severe hepatic congestion and portal hypertension.
